Endovascular Stroke Treatment: How Far Downstream Should We Go?

被引:1
|
作者
Friedrich, Benjamin [1 ]
Lobsien, Donald [2 ]
Wunderlich, Silke [3 ]
Maegerlein, Christian [1 ]
Pree, David [1 ]
Hoffmann, Karl-Titus [2 ]
Zimmer, Claus [1 ]
Kaesmacher, Johannes [1 ]
机构
[1] Tech Univ Munich, Klinikum Rechts Isar, Dept Diagnost & Intervent Neuroradiol, Ismaninger Str 22, D-80675 Munich, Germany
[2] Univ Hosp Leipzig, Dept Neuroradiol, Leipzig, Germany
[3] Tech Univ Munich, Dept Neurol, Klinikum Rechts Isar, Munich, Germany
关键词
Stroke; Endovascular treatment; Occlusion site; Distance to thrombus; Thrombolysis; MIDDLE CEREBRAL-ARTERY; ACUTE ISCHEMIC-STROKE; MECHANICAL THROMBECTOMY; INTRAVENOUS THROMBOLYSIS; THROMBUS; OCCLUSION; DISTANCE; RECANALIZATION; THERAPY; TRIAL;
D O I
10.1007/s00270-017-1830-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Endovascular thrombectomy has become the de facto standard in the treatment of large vessel occlusion. Previously, a correlation between good outcome and the occlusion site, measured by the 'distance to thrombus' (DT)-as the distance from the carotid T to the beginning of the thrombus-after thrombolysis could be shown. In the present study, we analyze the differences between the chances of a good outcome in respect of DT between patients treated endovascularly or intravenously. A dual-center database analysis including patients with stroke due to occlusion of the middle cerebral artery (MCA) was performed. Inclusion criteria were a completed treatment and full documentation of the clinical course. DT was measured in pre-treatment images. DT was correlated with the mRS at 90 days stratified according to the different treatment methods. A total of 280 patients could be included. We were able to show a correlation between the chances of good clinical outcome and the occlusion site measured by DT after i.v. thrombolysis. The outcome after endovascular treatment showed no correlation with DT (p = 0.227). After a DT of 26 mm, the chances of a good outcome after i.v. thrombolysis exceeded those after endovascular treatment. In patients with MCA occlusion, the probability for a good outcome after endovascular treatment is independent of the occlusion site in contrast to the treatment with i.v. thrombolysis. If the occlusion occurred in the periphery of the M2 region (DT > 26 mm), i.v. thrombolysis alone was superior to endovascular treatment in achieving a good outcome.
引用
收藏
页码:55 / 62
页数:8
相关论文
共 50 条
  • [41] SBRT for metastatic disease: how far can and should we go?
    Dahele, M.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S190 - S190
  • [42] From gasman to hospital saviour: how far should we go?
    Nesbit, I
    ANAESTHESIA, 2000, 55 (12) : 1234 - 1235
  • [43] Surgical criteria for blood transfusion: How far should we go?
    tenDuis, HJ
    TRIGGER FACTORS IN TRANSFUSION MEDICINE, 1996, 31 : 133 - 142
  • [44] Hypertrophic cardiomyopathy: How far should we go with genetic testing?
    Fahrner, Jill A.
    Murphy, Anne M.
    Gunay-Aygun, Meral
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2013, 161A (01) : 232 - 233
  • [45] Encyclopedic knowledge in terminology and translation: How far should we go?
    Dancette, J
    GLOBAL VISION, 1996, : 339 - 350
  • [46] KIDNEY TRANSPLANT CARDIOVASCULAR ASSESSMENT: HOW FAR SHOULD WE GO ?
    Klin, Pablo
    Lazzeri, Silvio
    Messina, Nahuel
    Gallucci, Emilse
    De Francesco, Juan
    Bridoux, Pablo
    Fortunato, Rita
    Raffaele, Pablo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [47] New opportunities in preventative dermatology: How far should we go?
    Zhang, Alexandra Y.
    Elmets, Craig A.
    Camp, William L.
    Elewski, Boni E.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (04) : 675 - 676
  • [48] Systems analysis in environmental engineering: how far should we go?
    Gujer, W
    WATER SCIENCE AND TECHNOLOGY, 2004, 49 (08) : 37 - 42
  • [49] HUMAN GENETIC-ENGINEERING - HOW FAR SHOULD WE GO
    GLOVER, JVC
    SOCIAL CONSEQUENCES OF GENETIC ENGINEERING, 1989, 820 : 193 - 214